Clinical Trial

Auricular Acupressure Reduces Rebound Effects After Discontinuation of Atropine

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
0.01% atropine is an effective measure for controlling myopia in children and is widely used in Asia for this purpose. However, there is a phenomenon of rebound and worsening of myopia after discontinuation of the medication. Auricular acupressure (AA) is gaining attention as a complementary therapy for myopia control. However, there is a lack of rigorous studies evaluating the effectiveness of AA in reducing rebound after discontinuing atropine eye drops in myopic children. Our study aims to assess the efficacy and safety of AA in reducing rebound after discontinuing atropine in myopic children.
Trial Details
NCT Number NCT07129889
Lead Sponsor Ningbo Eye Hospital
Conditions Myopia
Enrollment 180 participants
Start Date 2025-12-02
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-19